GRETCHEN COLLUM: Open Payments
NPI 1568508141 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,071 in 54 payments from 24 companies in 2025. Trend: 2023 $1,540 · 2024 $1,261 · 2025 $1,071
Food & beverage: $1,071
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $179 |
| Novo Nordisk Inc | 6 | $104 |
| Amgen Inc. | 5 | $86 |
| PFIZER INC. | 5 | $85 |
| Exact Sciences Corporation | 3 | $56 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| SANOFI-AVENTIS U.S. LLC | 2 | $54 |
| ABBVIE INC. | 3 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
Products named: FARXIGA, Wegovy, Cologuard Collection Kit, INGREZZA, TZIELD, PREVNAR 20, EVENITY, XIFAXAN.
Industry payments across SC — which companies pay providers there.
